Viewing nowNebilet M Tablet 1.25 mg (Nebivolol Hydrochloride)
Nebivolol Hydrochloride 1.3625mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

MFDS item code 202006679 · Approved 2020.09.28 · Insurance code 641806970
Adjunctive treatment of mild to moderate chronic stable heart failure in patients aged 70 years and older
This medication is used adjunctively along with standard treatment in elderly patients aged 70 and older with chronic stable heart failure, particularly those with mild to moderate chronic heart failure. It helps improve symptoms of heart failure and enhance the quality of life for patients.
1. Chronic heart failure 1) Elderly patients aged 70 years or older This medicine should be administered to patients with chronic stable heart failure who have had no history of acute heart failure during the past 6 weeks. The doses of cardiovascular medicines such as diuretics, digoxin, ACE inhibitors, and angiotensin II receptor blockers should have been stabilized by 2 weeks before starting this medicine. The dose should be gradually increased at 1~2-week intervals, taking the patient's condition into account, until the optimal dose for each patient is reached. Treatment should be initiated with nebivolol 1.25mg once daily and, if necessary, increased to 2.5mg once daily, 5mg once daily, and up to 10mg once daily. The maximum daily dose is 10mg. It may be taken with food. 2) Patients with renal impairment Because titration to the maximum tolerated dose is adjusted for each patient, no dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment (serum creatinine≥250μmol/L), as there is no experience with its use in these patients.
This medication should not be administered to certain patients. For example, it should not be used in individuals with hypersensitivity to this drug, history of bronchospasm or bronchial asthma, or patients with metabolic acidosis. It also should not be given to patients with very slow heart rates (bradycardia), severe heart failure, uncontrolled heart failure, low blood pressure, severe peripheral circulation disorders, patients with severely impaired liver or kidney function, pregnant women, and nursing mothers. Caution is needed when using this medication in patients with specific conditions such as chronic lung disease, untreated heart failure, peripheral circulation disorders, hyperthyroidism, and diabetes. Elderly patients also require careful monitoring, and dosages should be adjusted while observing their condition. During treatment, various side effects may occur, including skin rash, vision impairment, bradycardia, dizziness, headache, dyspepsia, shortness of breath, swelling, and fatigue. Particularly, deterioration of heart function or decreased heart rate may occur, so immediate consultation with healthcare professionals is necessary if symptoms worsen. This medication can interact with other drugs, thus caution is needed when taken alongside calcium channel blockers, antiarrhythmics, centrally acting antihypertensives, insulin, anticonvulsants, and others. Especially, the combination with certain medications may lead to further reduction in heart rate or blood pressure, so it is essential to strictly follow the physician's instructions. It is advisable not to take this medication during pregnancy or while nursing. Safety in children under 18 has not been established, so it is best not to administer this medication to them. In case of overdose, severe symptoms such as bradycardia, low blood pressure, bronchospasm, and acute heart failure may occur, necessitating immediate medical attention.
Rash, vision impairment, bradycardia, AV block, AV conduction delay, hypotension, heart failure, intermittent claudication, headache, dizziness, sensory abnormalities, depression, nightmares, fainting, diarrhea, constipation, nausea, dyspepsia, abdominal distension, vomiting, respiratory distress, bronchospasm, pruritus, erythematous rash, exacerbation of psoriasis, edema, fatigue, erectile dysfunction, vascular neurogenic edema, hallucinations, psychosis, confusion, cyanotic extremities, dry eyes, practolol-type conjunctival skin toxicity, Raynaud's phenomenon, orthostatic hypotension, drug intolerance, lower limb edema, insomnia, chest pain, palpitations, abdominal pain, polyuria, increased blood sugar, neck/shoulder pain, gastritis, chest discomfort, asthenia, inadequate effect, weight loss, cough, cold, dry cough, loss of appetite, anxiety, back pain, increased serum creatinine, tinnitus, dizziness, tremors, neuromuscular disease, gastroesophageal reflux, irritable bowel syndrome, thirst, gastric ulcer, gastrointestinal disorder, systemic weakness, facial edema, generalized edema, upper respiratory infection, rhinitis, sore throat, runny nose, restlessness, drowsiness, joint pain, flank pain, neck stiffness, back pain, increased BUN, bladder discomfort, cystitis, urinary stones, hematuria, diabetes mellitus, urticaria, tinea, sweating, dermatophytosis, cerebrovascular disease, peripheral vascular disease, flushing, nosebleed, increased ALT, increased AST, viral infection, thyroiditis, chronic myeloid leukemia
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius at room temperature.
White round tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowNebivolol Hydrochloride 1.3625mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Ellison Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 2.725mg
Tablet · Prescription medication
Erison Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.